Thomas Harrer
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
This article is a stub. |
Dr. Thomas Harrer, Universitatsklinikum Erlangen, Germany. He is a researcher for infections and immune deficiency, primary HIV[1].
EUROMENE[edit | edit source]
Dr. Harrer is a member of the Biomarkers Working Group of ME/CFS across Europe on behalf of EUROMENE, a European Union COST Action CA15111 not-for-profit research organization committed to tackling the cause and treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.[2]
Notable studies[edit | edit source]
- 2018, Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)[3] (Full text)
Talks and interviews[edit | edit source]
Online presence[edit | edit source]
- PubMed
- Website
- YouTube
See also[edit | edit source]
Learn more[edit | edit source]
References[edit | edit source]
- ↑ Primäre und sekundäre Defektimmunopathien
- ↑ http://www.cost.eu/COST_Actions/ca/CA15111?management
- ↑ Rasa, Santa; Nora-Krukle, Zaiga; Henning, Nina; Eliassen, Eva; Shikova, Evelina; Harrer, Thomas; Scheibenbogen, Carmen; Murovska, Modra; Prusty, Bhupesh K.; European Network on ME/CFS (EUROMENE) (October 1, 2018). "Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)". Journal of Translational Medicine. 16 (1). doi:10.1186/s12967-018-1644-y. ISSN 1479-5876. PMID 30285773.